Evidence map›Paper›PMID 21714577›Full record

ArticleJournal of the American Chemical Society2011

Luminescent gold nanoparticles with pH-dependent membrane adsorption.

Mengxiao Yu, Chen Zhou, Jinbin Liu, Julia D Hankins, Jie Zheng

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
10.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 192 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Probing the biological obstacles of nanomedicine with gold nanoparticles.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology · 2019
    Review
  17. Renal Clearable Luminescent Gold Nanoparticles: From the Bench to the Clinic.Angewandte Chemie (International ed. in English) · 2019
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Mengxiao YuDepartment of Chemistry, The University of Texas at Dallas, Richardson, Texas 75080, USA.
Chen Zhou
Jinbin Liu
Julia D Hankins
Jie Zheng
The University of Texas at Dallas · US

Funding

Cell-and Nucleus-Permeable Luminescent Gold NanoparticlesR21EB009853 · NIBIB · UNIVERSITY OF TEXAS DALLAS · PI ZHENG, JIE · 2009 to 2010
$394k
NIBIB NIH HHS R21 EB009853NIBIB NIH HHS R21EB009853
6 · The paper itself

Abstract

pH regulates many cellular processes and is also an indicator of disease progression. Therefore, pH-responsive materials often serve as either tools in the fundamental understanding of cell biology or medicine for disease diagnosis and therapy. While gold nanoparticles have broad biomedical applications, very few of them exhibit pH-dependent interactions with live cells in a native biological environment due to nonspecific serum protein adsorption. Herein, we report that by coating luminescent gold nanoparticles with a natural peptide, glutathione, and the simplest stable aminothiol, cysteamine, we enabled the nanoparticles to exhibit not only high resistance to serum protein adsorption but also pH-dependent adsorption onto live cell membranes in the presence of serum proteins. Incorporating this pH-dependent membrane adsorption behavior into gold nanoparticles could potentially catalyze new biomedical applications of metal nanoparticles in the fundamental understanding of biological processes as well as disease diagnosis and therapy, where pH changes are involved.

Indexed as

AdsorptionCell MembraneCysteamineGlutathioneGoldHeLa CellsHumansHydrogen-Ion ConcentrationLuminescenceLuminescent AgentsNanoparticlesCysteamineGlutathioneGoldLuminescent Agents

Identifiers

PMID21714577
PMCPMC3142579
OpenAlexW2043745621

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.